Caris Life Sciences, Inc. (CAI) vs Hinge Health, Inc. (HNGE)

A side-by-side comparison of Caris Life Sciences, Inc. and Hinge Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CAI vs HNGE

growth of $100 · dividends reinvested · last 1y
CAI +8.5% (+8.5%/yr)HNGE +147.5% (+147.5%/yr)HNGE compounded faster over this window
50100150200250Start $1002026$109$248
CAI HNGE

CAI vs HNGE: by the numbers

  • •CAI is the larger company ($8.54B vs $7.58B market cap).
  • •HNGE trades at the lower trailing earnings multiple (76.16 vs 84.38 P/E), one valuation lens rather than an overall verdict.
  • •HNGE converts more revenue to profit (15.15% vs 10.62% net margin).

Metrics side by side

Valuation

MetricCAIHNGE
P/E ratio84.3876.16
Forward P/E260.2842.26
P/S ratio8.6310.53
P/B ratio14.4322.02
EV / EBITDA47.6974.75
FCF yield1.72%3.79%

Profitability

MetricCAIHNGE
Gross margin69.66%84.52%
Operating margin5.56%-92.94%
Net margin10.62%15.15%
ROE17.77%31.68%
ROIC14.76%26.62%

Growth (annualized)

MetricCAIHNGE
Revenue CAGR (5Y)26.15%N/A

Frequently asked

Which has the lower trailing P/E, CAI or HNGE?
HNGE has the lower trailing P/E: CAI trades at 84.38 and HNGE at 76.16. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is CAI or HNGE more profitable?
HNGE runs the higher net margin — CAI at 10.62% versus HNGE at 15.15%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.